2
Orphan Designations
0
FDA Approvals
6
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| cancer-associated retinopathy | an autologous cell therapy product manufactured from tumor-infiltrating lymphocytes (TILs) that have been harvested from surgically resected tumor tissue and expanded ex vivo. | Orphan Designation | - |
| cutaneous melanoma | an autologous cell therapy product manufactured from tumor-infiltrating lymphocytes (TILs) that have been harvested from surgically resected tumor tissue and expanded ex vivo. | Orphan Designation | - |
| malignant cornea melanoma | an autologous cell therapy product manufactured from tumor-infiltrating lymphocytes (TILs) that have been harvested from surgically resected tumor tissue and expanded ex vivo. | Orphan Designation | - |
| stage I endometrioid carcinoma | autologous cell therapy product manufactured from tumor-infiltrating lymphocytes that have been harvested from surgically resected tumor tissue and expanded ex vivo | Orphan Designation | - |
| stage II endometrioid carcinoma | autologous cell therapy product manufactured from tumor-infiltrating lymphocytes that have been harvested from surgically resected tumor tissue and expanded ex vivo | Orphan Designation | - |
| stage IVb bladder cancer | autologous cell therapy product manufactured from tumor-infiltrating lymphocytes that have been harvested from surgically resected tumor tissue and expanded ex vivo | Orphan Designation | - |